Personal tools

Coexpression cluster:C4697: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C4697_Eosinophils_Mast_acute_non_CD14_Neutrophils_myelodysplastic |id=C4697 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C4697_Eosinophils_Mast_acute_non_CD14_Neutrophils_myelodysplastic
|full_id=C4697_Eosinophils_Mast_acute_non_CD14_Neutrophils_myelodysplastic
|id=C4697
|id=C4697
|ontology_enrichment_celltype=CL:0000037!8.60e-60!172;CL:0000566!8.60e-60!172;CL:0002032!4.34e-57!165;CL:0000837!4.34e-57!165;CL:0000988!1.54e-52!182;CL:0000738!4.98e-50!140;CL:0002031!1.86e-43!124;CL:0000763!4.84e-43!112;CL:0000049!4.84e-43!112;CL:0002087!3.47e-41!119;CL:0000766!5.39e-36!76;CL:0000557!2.13e-32!71;CL:0000839!1.75e-31!70;CL:0002009!1.80e-28!65;CL:0002194!5.55e-28!63;CL:0000576!5.55e-28!63;CL:0000040!5.55e-28!63;CL:0000559!5.55e-28!63;CL:0002057!7.80e-25!42;CL:0000860!4.55e-23!45;CL:0000945!5.03e-13!24;CL:0000826!5.03e-13!24;CL:0000542!3.49e-12!53;CL:0000051!3.49e-12!53;CL:0000838!1.04e-11!52;CL:0000236!1.42e-08!14
|ontology_enrichment_disease=DOID:2531!1.32e-09!51;DOID:0060083!1.32e-09!51;DOID:8692!1.35e-08!31;DOID:1240!1.25e-07!39
|ontology_enrichment_uberon=UBERON:0002390!1.48e-35!102;UBERON:0003061!1.48e-35!102;UBERON:0002193!7.72e-33!112;UBERON:0002371!7.86e-30!80;UBERON:0001474!1.43e-26!86;UBERON:0007023!2.12e-24!115;UBERON:0004765!1.71e-20!101;UBERON:0001434!1.71e-20!101;UBERON:0002405!3.38e-20!115;UBERON:0001049!2.72e-08!57;UBERON:0005068!2.72e-08!57;UBERON:0006241!2.72e-08!57;UBERON:0007135!2.72e-08!57;UBERON:0003080!2.55e-07!42;UBERON:0002780!2.85e-07!41;UBERON:0001890!2.85e-07!41;UBERON:0006240!2.85e-07!41
}}
}}

Revision as of 14:51, 21 May 2012


Full id: C4697_Eosinophils_Mast_acute_non_CD14_Neutrophils_myelodysplastic



Phase1 CAGE Peaks

Hg19::chr7:73624251..73624266,+p3@LAT2
Hg19::chr7:73624276..73624306,+p2@LAT2
Hg19::chr7:73624327..73624350,+p1@LAT2


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
hematopoietic stem cell8.60e-60172
angioblastic mesenchymal cell8.60e-60172
hematopoietic oligopotent progenitor cell4.34e-57165
hematopoietic multipotent progenitor cell4.34e-57165
hematopoietic cell1.54e-52182
leukocyte4.98e-50140
hematopoietic lineage restricted progenitor cell1.86e-43124
myeloid cell4.84e-43112
common myeloid progenitor4.84e-43112
nongranular leukocyte3.47e-41119
myeloid leukocyte5.39e-3676
granulocyte monocyte progenitor cell2.13e-3271
myeloid lineage restricted progenitor cell1.75e-3170
macrophage dendritic cell progenitor1.80e-2865
monopoietic cell5.55e-2863
monocyte5.55e-2863
monoblast5.55e-2863
promonocyte5.55e-2863
CD14-positive, CD16-negative classical monocyte7.80e-2542
classical monocyte4.55e-2345
lymphocyte of B lineage5.03e-1324
pro-B cell5.03e-1324
lymphocyte3.49e-1253
common lymphoid progenitor3.49e-1253
lymphoid lineage restricted progenitor cell1.04e-1152
B cell1.42e-0814
Uber Anatomy
Ontology termp-valuen
hematopoietic system1.48e-35102
blood island1.48e-35102
hemolymphoid system7.72e-33112
bone marrow7.86e-3080
bone element1.43e-2686
adult organism2.12e-24115
skeletal element1.71e-20101
skeletal system1.71e-20101
immune system3.38e-20115
neural tube2.72e-0857
neural rod2.72e-0857
future spinal cord2.72e-0857
neural keel2.72e-0857
anterior neural tube2.55e-0742
regional part of forebrain2.85e-0741
forebrain2.85e-0741
future forebrain2.85e-0741
Disease
Ontology termp-valuen
hematologic cancer1.32e-0951
immune system cancer1.32e-0951
myeloid leukemia1.35e-0831
leukemia1.25e-0739


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.